Biotoxtech Co., Ltd. announced a private placement of series 5 non-guaranteed private equity convertible bonds with bearer type interest part for a gross proceeds of KRW 18,000,000,000 on August 20, 2021. The transaction will include participation from Fund 1 for KRW 5,000,000,000, Fund 2 for KRW 2,500,000,000, Fund 3 for KRW 500,000,000, Fund 4 for KRW 2,000,000,000, Fund 5 for KRW 2,000,000,000, Fund 6 for KRW 600,000,000, Fund 7 for KRW 300,000,000, Fund 8 for KRW 100,000,000, BNK Securities Co., Ltd., Investment Arm for KRW 2,000,000,000, Mirae Asset Securities Co., Ltd. for KRW 1,000,000,000, EBEST HM New Technology Business Investment Association for KRW 2,000,000,000. The bonds will mature on August 24, 2026.

The bonds have a coupon rate of 0%. The bonds will be 100% converted into 1,738,122 common shares at a fixed conversion price of KRW 10,356 per share for an equity stake of 10.59%. The conversion period is from August 24, 2022 to July 24, 2026.

The payment date of the transaction is August 24, 2021. The securities issued in the transaction are subject to a lock up period of one year. The transaction has been approved by the board of directors of the company.